Future drugs from Amaryllis

A Danish research team has discovered possibolities to extract drugs fro Amaryllis.

By Sophia Carlsson

January 21, 2009 12:00 AM

A brand new research

project from the Department of Pharmacy at the University of Copenhagen has proved that the Amaryllis plant contains substances that be used in the treatment aganst disease in the central nerve system, for example Alzheimer’s disease.

The active substance

in, among others, Galanthamin, which can be extracted from snowdrops. It is already registred as a drug substance in Reminyl, used against dementia.

The research team

has now recieved a EU grant of DKK 1,6 million to continue this research project and to, hopefully, find the base for new drugs in the future.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.